cemka > Publications > Oncologie

Classer les publications sur l'année

  • Increased cancer incidence in patients with pre-existing heart failure: results from a French nationwide cohort study

    MIRABEL M , NEVORET C , DOMENGE O , EMERY C ,  A DE BOER R ,  EMPANA J-P , HULOT J-S

    European Journal of Preventive Cardiology,  ; 2025

  • Économie de la santĂ©

    Real-life evaluation of the care pathway of patients eligible for axicabtagene ciloleucel treatment: Analysis of a multicenter retrospective cohort (IMPA-CT study)

    CARTRON G, THIEBLEMONT C , BORGET I, RIOUFOL C, BERTHET M, PORTAL C, BAUJAT C, ALAOUI E , BAFFERT S, LACROIX D, BORIES P, YAKOUB-AGHA I, HOUOT R

    Bulletin du Cancer ; 2024;111 (11:1020-1029)

  • Économie de la santĂ©

    Impact of precariousness on breast cancer care in the Île-de-France region: Results of the DESSEIN study

    NGO C, BONSANG-KITZIS H,CHARREIRE H, BOCHATON A, CONTI B , BAFFERT S, BEAUVAIS A, ARNOUX A, LECURU F, DESPRES C

    Bulletin du Cancer ; 2024;111 (7-8):635-645

  • Économie de la santĂ©

    Time and space in the care pathways of women suffering from breast cancer

    DESPRES C, BOCHATON A, CONTI B , CHARREIRE H , BAFFERT S , NGO C

    Bulletin du Cancer ; 2024;111 (7-8):646-660

  • Économie de la santĂ©

    Influence of geographic access and socioeconomic characteristics on breast cancer outcomes: A systematic review.

    CONTI B, BOCHATON A, CHARREIRE H, KITZIS-BONSANG H, DESPRÈS C, BAFFERT S, NGÔ C.

    PLoS One ; 2022;17(7):e0271319

  • Autres

    Management and Health Resource Use of Patients with Metastatic Renal Cell Carcinoma treated with Systemic Therapy over 2014-2017 in France: a National Real-World Study

    ESCUDIER B, DE ZELICOURT M, BOUROUINA R, NEVORET C,THIERY-VUILLEMIN A

    Clinical Genitourinary Cancer ; 2022;20(6):533-542

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting.

    HARROW B, FAGNANI F, NEVORET C, TRUONG-THANH XM, DE ZÉLICOURT M, DE MESTIER L.

    Adv Ther ; 2022;39:1754-1771

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: A nationwide retrospective analysis.

    NEUZILLET C, EMERY C, TEISSIER C, BOUEE S, LIEVRE A.

    Lancet Reg Health Eur ; 2022;15:100324

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in EGFR-mutated non-small-cell lung cancer: a real life study

    GIRARD N, MORO-SIBILOT D, BOUEE S, EMERY C, TORRETON E, LE LAY K, LUCIANI L, MARITAZ C, CHOUAID C

    Future Oncol ; 2020;16(16),1115-1124

  • Économie de la santĂ©

    Absenteeism and indirect costs during the year following the diagnosis of an operable breast cancer: A prospective multicentric cohort study

    FERRIER C, THEBAUT C, BAFFERT S, ASSELAIN B, ROUZIER R,HEQUET D

    J Gynecol Obstet Hum Reprod ; 2020;50(6)

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Effectiveness of sequencing TKIs in patients with EGFR mutation-positive non-small cell lung cancer (NSCLC): A French national medical-administrative claim database analysis

    GIRARD N, BOUEE S, MORO-SIBILOT D, EMERY C, LE LAY K, LUCIANI L, MARITAZ C, CHOUAID C

    Annals of Oncology ; 2019;30(5):v627-v628

  • Pharmaco-EpidĂ©miologie

    Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in EGFR-mutated non-small-cell lung cancer: a real life study

    GIRARD N, MORO-SIBILOT D, BOUEE S, EMERY C, TORRETON E, LE LAY K, LUCIANI L, MARITAZ C, CHOUAID C.

    Future Oncol ; 2020;16(16),1115-1124

  • Économie de la santĂ©

    Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study

    HEQUET D, HUCHON C, SOILLY AL, ASSELAIN B, BERSENEFF H, TRICHOT C, COMBES A, ALVES K, NGUYEN T, ROUZIER R, BAFFERT S.

    PLoS One ; 2019;14(7)

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in france: real world data from the permanent sample of national health insurance beneficiairies.

    LAFUMA A, COTTÉ FE, LE TOURNEAU C, EMERY C, GAUDIN AF, TORRETON E, GOURMELEN J, BONASTRE J.

    J Med Econ ; 2019;22(7):698-705

  • Économie de la santĂ©

    Cost-effectiveness of web-based patient-reported outcome surveillance in lung cancer patients.

    LIZÉE T, BASCH E, TRÉMOLIÈRES P, VOOG E, DOMONT J, PEYRAGA G, URBAN T, BENNOUNA J, SEPTANS A-L, BALAVOINE M, DETOURNAY B, DENIS F.

    J Thorac Oncol ; 2019;14(6):1012-1020